EVIO Labs Massachusetts Announces Relocation to Framingham
September 18, 2018 at 08:28 pm IST
Share
EVIO Inc. announced that its Massachusetts lab has engaged in a Community Host agreement with the City of Framingham to proceed with licensing as an independent testing laboratory under the commission's recently adopted adult use regulations. This is on the heels of the announcement that the lab had received ISO 17025 accreditation and is awaiting licensing approval from the Cannabis Control Commission. The lab will move to a 5,000 square foot facility that is centrally located to serve marijuana establishments statewide. Massachusetts law requires that all recreational marijuana products have been tested by a Commission-licensed independent laboratory for contaminants and potency levels. The Commonwealth's adult-use cannabis market is expected to exceed $1 billion by 2021.
EVIO, Inc. is a diversified holding company. The Company provides analytical testing services to the agricultural and pharmaceutical industries, primarily for cannabis, hemp, and related products. The Company offers residential and commercial construction services. The Company also offers research and development and consulting services for participants in the cannabis and hemp industries. The Company tests products to verify the regulatory requirements for sale. Its subsidiaries include Smith Scientific Industries, LLC; Greenhaus Analytical Labs, LLC; Viridis Analytics, LLC; EVIO Labs OR, Inc.; C3 Labs, LLC; EVIO Labs Humboldt, LLC and Keystone Labs, Inc.